Hematology/Oncology

Top Story

Elective neck dissection reduces regional recurrence in node-negative oral tongue carcinoma

July 28, 2016

Elective neck dissection reduced risk for regional node recurrence and improved disease-specific survival compared with management and observation among patients with early-stage squamous cell carcinoma of the oral tongue, according to results of a literature review.

However, elective neck dissection (END) failed to improve OS.

In the Journals

Use of EHRs, CPOE associated with physician burnout, dissatisfaction

July 27, 2016
Physicians reported low satisfaction with their electronic health records and computerized physician order entry, according to findings published in Mayo Clinic
Health Care Legislative and Regulatory Update

Are the holiday baskets really worth the risk?

July 27, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published…
In the Journals

Melanoma in situ incidences increase at faster rate than invasive melanoma

July 27, 2016
Incidence of melanoma in situ increased at a faster rate than invasive melanoma, with the two melanomas displaying epidemiological and clinical differences, according to…
More News Headlines »
CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Video

VIDEO: Selecting patients for prolonged letrozole therapy requires discussion of benefits, drawbacks

July 13, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Current Issues
View the Current Issue
HemOnc Today